Sonia Gulati

Sonia Gulati has an extensive background in the life sciences industry, with experience in investment management and company leadership roles. Currently serving as the Principal at Global BioAccess Fund, Sonia oversees funding for early-stage companies in the medical field. Additionally, Sonia holds various director positions in different companies including TigaTx, 1200 Pharma, Pinpoint Therapeutics, GLS Therapeutics, NuvoNuro, Actinobac Biomed, Inc., and NeuroNovus Therapeutics. Previously, Sonia worked as an Executive in Residence at Kairos Ventures and as an Assistant Director at New York Ventures. Gulati holds a Doctor of Philosophy (PhD) from Columbia University Graduate School of Arts and Sciences and a Bachelor of Arts (B.A.) from Barnard College, Columbia University.